We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
-13.86%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$1.39B
AUM Growth
+$23.5M
Cap. Flow
+$245M
Cap. Flow %
17.64%
Top 10 Hldgs %
24.95%
Holding
4,841
New
999
Increased
1,367
Reduced
1,469
Closed
908

Sector Composition

Rank Sector Weight
1 Healthcare 6.26%
2 Financials 5.86%
3 Technology 5.03%
4 Energy 4.85%
5 Consumer Discretionary 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BSM icon
1426
Black Stone Minerals
BSM
$3B
$40K ﹤0.01%
+2,580
New +$43.6K
CHN
1427
DELISTED
China Fund
CHN
$40K ﹤0.01%
+2,386
New +$42.4K
CRVS icon
1428
Corvus Pharmaceuticals
CRVS
$1.17B
$40K ﹤0.01%
10,810
+9,140
+547% +$62.3K
HSBC icon
1429
HSBC
HSBC
$356B
$40K ﹤0.01%
986
-1,515
-61% -$60.7K
ITT icon
1430
ITT
ITT
$19.1B
$40K ﹤0.01%
829
-7,576
-90% -$400K
NEE icon
1431
NextEra Energy
NEE
$177B
$40K ﹤0.01%
924
-6,016
-87% -$263K
NGS icon
1432
Natural Gas Services Group
NGS
$477M
$40K ﹤0.01%
2,442
+2,034
+499% +$38.9K
NPO icon
1433
Enpro
NPO
$7.05B
$40K ﹤0.01%
673
-416
-38% -$27.6K
NVS icon
1434
Novartis
NVS
$297B
$40K ﹤0.01%
519
-1,171
-69% -$91.2K
PSCF icon
1435
Invesco S&P SmallCap Financials ETF
PSCF
$27.3M
$40K ﹤0.01%
836
+714
+585% +$38.1K
RMTI icon
1436
Rockwell Medical
RMTI
$28.2M
$40K ﹤0.01%
162
+148
+1,057% +$58.9K
VRT icon
1437
Vertiv
VRT
$105B
$40K ﹤0.01%
+4,083
New +$39.9K
USX
1438
DELISTED
U.S. Xpress Enterprises, Inc. Class A Common Stock
USX
$40K ﹤0.01%
7,120
-1,147
-14% -$9.63K
FRC
1439
DELISTED
First Republic Bank
FRC
$40K ﹤0.01%
463
-4,322
-90% -$394K
HTGM
1440
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$40K ﹤0.01%
89
+78
+709% +$48.3K
ALTA
1441
DELISTED
Altabancorp
ALTA
$40K ﹤0.01%
1,335
+1,003
+302% +$32K
CDOR
1442
DELISTED
Condor Hospitality Trust, Inc. Common Stock
CDOR
$40K ﹤0.01%
5,801
+5,102
+730% +$50K
BKSC
1443
DELISTED
Bank of South Carolina
BKSC
$40K ﹤0.01%
2,192
+545
+33% +$10.6K
STL
1444
DELISTED
Sterling Bancorp
STL
$40K ﹤0.01%
2,431
-9,820
-80% -$183K
AZPN
1445
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$40K ﹤0.01%
+492
New +$40K
ABUS icon
1446
Arbutus Biopharma
ABUS
$915M
$39K ﹤0.01%
10,209
+8,647
+554% +$42.6K
AIHS icon
1447
Senmiao Technology Ltd
AIHS
$22.6M
$39K ﹤0.01%
103
+34
+49% +$14.8K
ANET icon
1448
Arista Networks
ANET
$238B
$39K ﹤0.01%
2,992
+416
+16% +$5.97K
CHT icon
1449
Chunghwa Telecom
CHT
$33B
$39K ﹤0.01%
+1,100
New +$38.3K
CRD.A icon
1450
Crawford & Co Class A
CRD.A
$669M
$39K ﹤0.01%
4,417
+2,817
+176% +$25.4K

Similar funds

Tower Research Capital (TRC)'s Q4 2018 Portfolio in Review

As of Q4 2018, Tower Research Capital (TRC) held 4,841 positions worth $1.39B, up 1.7% from $1.36B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Tower Research Capital (TRC) deployed $245M of net new capital in Q4 2018, opening 999 new positions and adding to 1,367 existing holdings. Its largest new stake was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 6.3% of assets, down from 6.8% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $124M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2018 buy was iShares S&P 500 Value ETF: 55,235 shares worth $5.59M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2018, an estimated $123M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $124M.
  • Tower Research Capital (TRC) fully exited State Street Energy Select Sector SPDR ETF in Q4 2018, selling an estimated $26.3M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 25% of its $1.39B portfolio in Q4 2018.
  • Tower Research Capital (TRC) opened 999 new positions and closed 908 in Q4 2018.
  • Tower Research Capital (TRC)'s portfolio value rose 1.7% quarter-over-quarter to $1.39B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2018, filed 14 Feb 2019.